Table 1. Descriptive characteristics of the study sample (mean ± SD).
Subjects’ physical characteristics | Age (years) | 50.2 ± 10.8 |
Mass (kg) | 69.6 ± 15.2 | |
Height (cm) | 160.5 ± 5.3 | |
Body mass index (kg/m2) | 27.5 ± 6.8 | |
Body fat mass (kg) | 26.4 ± 12.36 | |
Body mucle mass (kg) | 23.7 ± 3.4 | |
1RM bilateral leg-press (kg) | 117.4 ± 24.8 | |
1RM bilateral leg-press (normalized per kg of body mass) | 1.69 ± 0.32 | |
Treatment | Chemotherapy (sessions) | 7.7 ± 3.9 |
Radiotherapy (sessions) | 26.4 ± 6.1 | |
Medical information | Tumor type, HR+HER2-/HR+HER2+/HR-HER2+/HR-HER2-, (%) | 65.1/18.3/3.3/13.3 |
Surgical procedure, n (%) Tumorectomy/Mastectomy | 15 (71.4)/6 (28.6) | |
Lymph node resection, n (%) | 9 (42.9) | |
Lymphedema, n (%) | 2 (9.5) | |
Endocrine therapy, n (%) | 18 (85.7) |
Note:
Data are mean ± standard deviation. 1RM, one-repetition maximum; HR, hormone receptor; HER2, human epidermal growth factor receptor 2.